clinical trials

News

GSK abandons cough drug added in $2bn Bellus deal

Three years after buying Bellus Health and its chronic cough candidate camlipixant for around $2 billion, GSK is abandoning the programme.

News

Novo's Wegovy pill cleared for weight loss in EU

The EU has approved Novo Nordisk's pill formulation of weight-loss therapy Wegovy, keeping the company a step ahead of arch rival Eli Lilly.

News

Biogen, Ionis trumpet Alzheimer's data, but shares dip

Biogen and Ionis have revealed the first clinical results with tau-targeting Alzheimer's drug candidate diranersen, to a mixed response.

News

First trial of Bundibugyo Ebola vaccine starts in UK

Oxford University has launched what it says is the world's first phase I trial of a vaccine specifically designed to protect against Bundibugyo Ebola.

News

Major trial launched to explore GLP-1 benefit in dementia

A $100m trial has been launched to see if lifestyle changes coupled with GLP-1 agonists or similar incretins can reduce the risk of dementia.

News

GSK to file Jemperli for rectal cancer after phase 3 readout

GSK's pivotal AZUR-1 trial of Jemperli monotherapy to delay or eliminate surgery in pre-operative rectal cancer has delivered a positive result.

GSK abandons cough drug added in $2bn Bellus deal

Novo's Wegovy pill cleared for weight loss in EU

Biogen, Ionis trumpet Alzheimer's data, but shares dip

First trial of Bundibugyo Ebola vaccine starts in UK

Major trial launched to explore GLP-1 benefit in dementia

GSK to file Jemperli for rectal cancer after phase 3 readout

Getting predictive technologies to patients, with Concr

Discover a new era of healthcare panel engagement: Grounded ...

clinical trials

Editor's Picks